This is a preview of subscription content, log in via an institution to check access.
REFERENCE
Sancar AA, Yegenoglu S, De Vries R, Postma MJ, Simsek N, Pechlivanoglou P, Unal S.Vancomycin vs teicoplanin in the treatment of Gram-positive infections: a pharmacoeconomic analysis in a Turkish University Hospital. Pharmacy World and Science 30: 916-923, No. 6, Dec 2008
Rights and permissions
About this article
Cite this article
No difference in costs of vancomycin, teicoplanin. Pharmacoecon. Outcomes News 570, 4 (2009). https://doi.org/10.2165/00151234-200905700-00011
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200905700-00011